Arizona State Retirement System’s Albany Molecular Research Inc AMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-11,686
Closed -$254K 1538
2017
Q2
$254K Buy
11,686
+100
+0.9% +$1.81K ﹤0.01% 1422
2017
Q1
$163K Buy
11,586
+100
+0.9% +$1.64K ﹤0.01% 1465
2016
Q4
$215K Hold
11,486
﹤0.01% 1441
2016
Q3
$190K Sell
11,486
-2,600
-18% -$38.5K ﹤0.01% 1431
2016
Q2
$189K Buy
14,086
+300
+2% +$4.38K ﹤0.01% 1431
2016
Q1
$211K Buy
13,786
+400
+3% +$6.27K ﹤0.01% 1398
2015
Q4
$266K Buy
13,386
+400
+3% +$7.6K ﹤0.01% 1361
2015
Q3
$226K Buy
+12,986
New +$264K ﹤0.01% 1377
2014
Q4
$268K Buy
16,500
+100
+0.6% +$1.83K ﹤0.01% 1452
2014
Q3
$361K Buy
16,400
+3,400
+26% +$69.6K ﹤0.01% 1378
2014
Q2
$261K Buy
13,000
+200
+2% +$3.39K ﹤0.01% 1449
2014
Q1
$237K Buy
+12,800
New +$176K ﹤0.01% 1455

Other funds holding AMRI

Arizona State Retirement System's AMRI Position: Q3 2017 in Review

Arizona State Retirement System sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 11,686 shares — an estimated $254K sold.

Arizona State Retirement System first reported a position in AMRI in Q1 2014 and held it in 12 quarters. The position peaked at $361K in Q3 2014. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Arizona State Retirement System reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Arizona State Retirement System sold 11,686 Albany Molecular Research Inc shares in Q3 2017, an estimated $254K.
  • Arizona State Retirement System first reported a position in Albany Molecular Research Inc in Q1 2014 and held it in 12 quarters.
  • Arizona State Retirement System's Albany Molecular Research Inc position peaked at $361K in Q3 2014.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Arizona State Retirement System's 13F filing for Q3 2017, filed 14 Nov 2017.